Cen Xie

Title: Cen Xie: Innovator in Farnesoid X Receptor Inhibitors

Introduction

Cen Xie is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medicine through his innovative research and patents. His work primarily focuses on the development of inhibitors for the farnesoid X receptor, which have important implications for treating various metabolic disorders.

Latest Patents

Cen Xie holds 2 patents related to inhibitors of the farnesoid X receptor. His latest patents disclose compounds that are useful in treating or preventing obesity, type 2 diabetes, insulin resistance, and non-alcoholic fatty liver disease in mammals. The patents detail a composition that includes a pharmaceutically suitable carrier and at least one compound of the invention. Additionally, methods for inhibiting the farnesoid X receptor and treating obesity in mammals are also outlined.

Career Highlights

Throughout his career, Cen Xie has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the Penn State Research Foundation. His experience in these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Cen Xie has collaborated with notable colleagues, including Frank J Gonzalez and Changtao Jiang. These collaborations have further enriched his research and innovation in the field.

Conclusion

Cen Xie's work in developing farnesoid X receptor inhibitors showcases his dedication to advancing medical science. His contributions have the potential to impact the treatment of critical health issues, making him a significant figure in the field of innovation.